NO941310D0 - Sammensetning og fremgangsmåte for behandling av hepatitt C - Google Patents

Sammensetning og fremgangsmåte for behandling av hepatitt C

Info

Publication number
NO941310D0
NO941310D0 NO941310A NO941310A NO941310D0 NO 941310 D0 NO941310 D0 NO 941310D0 NO 941310 A NO941310 A NO 941310A NO 941310 A NO941310 A NO 941310A NO 941310 D0 NO941310 D0 NO 941310D0
Authority
NO
Norway
Prior art keywords
thymosin
hepatitis
treatment
composition
immune system
Prior art date
Application number
NO941310A
Other languages
English (en)
Norwegian (no)
Other versions
NO941310L (no
Inventor
Paul Chretian
Milton Mutchnick
Kenneth E Sherman
Original Assignee
Alpha 1 Biomedicals Inc
Milton Mutchnick
Kenneth E Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha 1 Biomedicals Inc, Milton Mutchnick, Kenneth E Sherman filed Critical Alpha 1 Biomedicals Inc
Publication of NO941310D0 publication Critical patent/NO941310D0/no
Publication of NO941310L publication Critical patent/NO941310L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Beans For Foods Or Fodder (AREA)
NO941310A 1991-09-13 1994-04-12 Sammensetning og fremgangsmåte for behandling av hepatitt C NO941310L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75954491A 1991-09-13 1991-09-13
PCT/US1992/007556 WO1993005806A1 (en) 1991-09-13 1992-09-08 Composition and method of treating hepatitis c

Publications (2)

Publication Number Publication Date
NO941310D0 true NO941310D0 (no) 1994-04-12
NO941310L NO941310L (no) 1994-04-12

Family

ID=25056052

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941310A NO941310L (no) 1991-09-13 1994-04-12 Sammensetning og fremgangsmåte for behandling av hepatitt C

Country Status (22)

Country Link
US (3) US6001799A (cg-RX-API-DMAC10.html)
EP (1) EP0603305B1 (cg-RX-API-DMAC10.html)
JP (1) JP3228512B2 (cg-RX-API-DMAC10.html)
KR (1) KR100254082B1 (cg-RX-API-DMAC10.html)
AT (1) ATE152914T1 (cg-RX-API-DMAC10.html)
AU (1) AU667327B2 (cg-RX-API-DMAC10.html)
CA (1) CA2119006C (cg-RX-API-DMAC10.html)
CZ (1) CZ286827B6 (cg-RX-API-DMAC10.html)
DE (1) DE69219782T2 (cg-RX-API-DMAC10.html)
DK (1) DK0603305T3 (cg-RX-API-DMAC10.html)
ES (1) ES2103966T3 (cg-RX-API-DMAC10.html)
FI (1) FI107879B (cg-RX-API-DMAC10.html)
GR (1) GR3024025T3 (cg-RX-API-DMAC10.html)
HU (1) HU221006B1 (cg-RX-API-DMAC10.html)
MX (1) MX9205240A (cg-RX-API-DMAC10.html)
NO (1) NO941310L (cg-RX-API-DMAC10.html)
RO (1) RO111991B1 (cg-RX-API-DMAC10.html)
RU (1) RU2104010C1 (cg-RX-API-DMAC10.html)
SG (1) SG64897A1 (cg-RX-API-DMAC10.html)
TW (1) TW224053B (cg-RX-API-DMAC10.html)
WO (1) WO1993005806A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA926964B (cg-RX-API-DMAC10.html)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224053B (cg-RX-API-DMAC10.html) * 1991-09-13 1994-05-21 Paul B Chretien
WO1995011688A1 (en) * 1992-02-06 1995-05-04 Sciclone Pharmaceuticals Method for treating hepatitis b carriers with minimal disease
AU751199B2 (en) * 1992-07-13 2002-08-08 Government Of The United States Of America As Represented By The Secretary Of The Army Composition and method of treating hepatitis B
WO1994001125A1 (en) * 1992-07-13 1994-01-20 Sherman Kenneth E Composition and method of treating hepatitis b
CN1072961C (zh) * 1993-03-05 2001-10-17 施塞克龙药品公司 治疗对干扰素治疗无反应者的丙型肝炎的方法
US6200952B1 (en) * 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
TW249754B (cg-RX-API-DMAC10.html) * 1993-10-26 1995-06-21 Alpha I Biomedicals Inc
KR100298859B1 (ko) * 1993-11-05 2001-10-22 더 보드 오브 가버너스 오브 웨인 스테이트 유니버시티 대상부전성간질환을가진환자의치료방법및조성물
JP3837769B2 (ja) * 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
GEP20012489B (en) * 1996-02-28 2001-07-25 Ifi Inst Farmacoterapico Italiano S P A Use of Natural Human α-Interferon
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
NZ547204A (en) 2000-05-26 2008-01-31 Idenix Cayman Ltd Methods and compositions for treating flaviviruses and pestiviruses
US7208167B2 (en) * 2000-08-07 2007-04-24 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis C with thymosin and peptide combination therapy
KR100851861B1 (ko) * 2000-08-07 2008-08-13 사이클론 파아머슈티컬 인코오퍼레이티드 티모신, 인터페론 및 리바비린을 사용한 씨 형 간염의치료
AU2002227252A1 (en) * 2000-12-01 2002-06-11 Cornell Research Foundation Animal model for flaviviridae infection
RU2211703C2 (ru) * 2001-06-08 2003-09-10 ООО НТЦ "Юпитер-2" Антистрессорное и ноотропное средство с антивирусным и иммуностимулирующим действием
US7138376B2 (en) * 2001-09-28 2006-11-21 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides
WO2003030613A2 (en) * 2001-10-05 2003-04-17 Intermune, Inc. Methods of treating liver fibrosis and hepatitis c virus infection
WO2003035010A2 (en) * 2001-10-26 2003-05-01 Rhode Island Hospital Thymosin augmentation of genetic immunization
UA80957C2 (en) * 2001-11-01 2007-11-26 Sciclone Pharmaceuticals Inc Method of administering a thymosin alpha 1 peptide
NZ534811A (en) * 2002-02-14 2007-07-27 Pharmasset Inc Modified fluorinated nucleoside analogues
AU2003248748A1 (en) 2002-06-28 2004-01-19 Idenix (Cayman) Limited 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
MY140819A (en) 2002-06-28 2010-01-29 Idenix Caymans Ltd Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
NZ537662A (en) 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7824851B2 (en) 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
KR20050109918A (ko) 2002-12-12 2005-11-22 이데닉스 (케이만) 리미티드 2'-분지형 뉴클레오시드의 제조 방법
GB0301879D0 (en) * 2003-01-27 2003-02-26 Regent Res Llp HCV combination therapy
JP4149296B2 (ja) * 2003-03-26 2008-09-10 株式会社ルネサステクノロジ 半導体記憶装置
EP1613340B1 (en) * 2003-03-28 2010-05-12 SciClone Pharmaceuticals, Inc. Treatment of aspergillus infections with thymosin alpha 1
CN100342907C (zh) * 2003-03-28 2007-10-17 希克龙制药公司 胸腺素α1在制备用于治疗或预防哺乳动物中曲霉菌感染的药物组合物中的应用
US20100311656A1 (en) * 2003-04-23 2010-12-09 Sciclone Pharmaceuticals, Inc. Treatment or prevention of respiratory viral infections with alpha thymosin peptides
CA2734052A1 (en) 2003-05-30 2005-01-13 Pharmasset, Inc. Modified fluorinated nucleoside analogues
CN1852915A (zh) 2003-07-25 2006-10-25 艾登尼科斯（开曼）有限公司 治疗包括丙型肝炎的黄病毒科病毒所致疾病的嘌呤核苷类似物
WO2005021007A1 (fr) * 2003-08-28 2005-03-10 Obschestvo S Ogranichennoi Otvetstvennostju 'berezovy Mir' Prevention et traitement de l'hepatite virale b
CN1980657A (zh) 2004-05-05 2007-06-13 耶鲁大学 新颖的抗病毒赛菊宁黄质类似物
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
BRPI0515279A (pt) 2004-09-14 2008-07-15 Pharmasset Inc preparação de ribofuranosil pirimidinas e purinas 2'fluoro-2'-alquil- substituìdas ou outras opcionalmente substituìdas e seus derivados
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
WO2007075876A2 (en) 2005-12-23 2007-07-05 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
US8337828B2 (en) * 2006-05-02 2012-12-25 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
ES2288118B1 (es) * 2006-05-10 2008-11-01 Bcn Peptides, S.A. Procedimiento para sintetizar timosinas.
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
TW200946541A (en) * 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
WO2010042697A1 (en) * 2008-10-08 2010-04-15 University Of Miami Regulation of lymphocytes and uses therefor
WO2010075554A1 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Synthesis of purine nucleosides
EP2376514A2 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
US8716262B2 (en) 2008-12-23 2014-05-06 Gilead Pharmasset Llc Nucleoside phosphoramidates
CN102458470B (zh) 2009-05-08 2016-01-20 赛生制药有限公司 作为疫苗增强剂的α胸腺素肽
TWI583692B (zh) * 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
RS54368B1 (sr) 2010-03-31 2016-04-28 Gilead Pharmasset Llc Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-diokso-3,4-dihidropirimidin-1-(2h)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
CA2818853A1 (en) 2010-11-30 2012-06-07 Gilead Pharmasset Llc 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
US8809354B2 (en) 2011-12-31 2014-08-19 Sheikh Riazuddin 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
CN103800293B (zh) * 2012-11-09 2015-10-21 长春海悦药业有限公司 一种含有胸腺法新的药物组合物及其制剂
SG11201600919UA (en) 2013-08-27 2016-03-30 Gilead Pharmasset Llc Combination formulation of two antiviral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216056B (it) * 1988-03-11 1990-02-22 Sclavo Spa Composizioni farmaceutiche contenenti timosina alfa 1.
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
TW224053B (cg-RX-API-DMAC10.html) * 1991-09-13 1994-05-21 Paul B Chretien

Also Published As

Publication number Publication date
CA2119006C (en) 2005-08-23
ATE152914T1 (de) 1997-05-15
DK0603305T3 (da) 1997-09-01
FI941133A0 (fi) 1994-03-10
JPH06510998A (ja) 1994-12-08
DE69219782D1 (de) 1997-06-19
NO941310L (no) 1994-04-12
RU2104010C1 (ru) 1998-02-10
CZ55194A3 (en) 1994-10-19
ES2103966T3 (es) 1997-10-01
US20070218033A1 (en) 2007-09-20
US6001799A (en) 1999-12-14
HK1021687A1 (en) 2000-06-23
EP0603305B1 (en) 1997-05-14
ZA926964B (en) 1993-04-26
EP0603305A1 (en) 1994-06-29
AU2644792A (en) 1993-04-27
RU94022480A (ru) 1996-07-20
SG64897A1 (en) 1999-05-25
KR100254082B1 (ko) 2000-09-01
GR3024025T3 (en) 1997-10-31
HU9400758D0 (en) 1994-06-28
DE69219782T2 (de) 1997-10-09
TW224053B (cg-RX-API-DMAC10.html) 1994-05-21
HUT75166A (en) 1997-04-28
RO111991B1 (ro) 1997-04-30
FI107879B (fi) 2001-10-31
HU221006B1 (hu) 2002-07-29
JP3228512B2 (ja) 2001-11-12
US5849696A (en) 1998-12-15
AU667327B2 (en) 1996-03-21
FI941133L (fi) 1994-03-10
CA2119006A1 (en) 1993-04-01
CZ286827B6 (cs) 2000-07-12
WO1993005806A1 (en) 1993-04-01
MX9205240A (es) 1993-07-01

Similar Documents

Publication Publication Date Title
NO941310D0 (no) Sammensetning og fremgangsmåte for behandling av hepatitt C
EP0717592A4 (en) METHOD AND COMPOSITION FOR TREATING THE APATHIE DEMOTIVATION SYNDROME
DK0380230T3 (da) Immunogene sammensætninger mod gastrin-peptider
AU4205789A (en) Method and composition for the treatment and prevention of viral infections
FR2709966B1 (fr) Vaccin pour la prévention du syndrome respiratoire et de la reproduction du porc.
DE69329558D1 (de) Verfahren zur Behandlung von Multiplesklerose
FI943028L (fi) Happoa kestävä FGF-koostumus ja menetelmä ruoansulatuskanavassa esiintyvien, haavaumia aiheuttavien sairauksien hoitamiseksi
SG46620A1 (en) Method and composition foor the treatment of autoimmune hepatitis
EP0325129A3 (en) Disubstituted pyridines
FI924363A0 (fi) Foerfarande foer behandling och/eller diagnostisering av mjukvaevnadstumoerer.
FI941705A0 (fi) Menetelmä viruspatogeenien läpipääsyn estämiseksi
GB9109478D0 (en) Antivenoms
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
DE3884652D1 (de) Gate-Ausschaltthyristor und Verfahren zu dessen Herstellung.
ATE107166T1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
NO933628D0 (no) Fremgangsmaate og blanding for behandling av herpes-infeksjoner
MY110041A (en) Composition and method of treating hepatitis c
DK0497356T3 (da) Sammensætninger og fremgangsmåde til tumorer i blødt væv
NO961775L (no) Fremgangsmåte og sammensetning for behandling av pasienter med dekompensert leversykdom
ZA897105B (en) Method and composition for the treatment of viral infections
NO169182C (no) Doseringsbeholder for opptak og levering av midler for behandling av toey.
DK143292D0 (da) Fremgangsmaade og apparatur til blivende at foroege et langstrakt traeemnes boejelighed
NO910474D0 (no) Oppvarmet transportoer og metode for desinfisering av forurenset sykehus-avfall med liten stoerrelse.